Anti-diabetic nutraceutical composition from palm leaf extract
Abstract
A comestible composition with anti-diabetic property which is effective in lowering the blood glucose and help reduce oxidative stress in diabetics and have anti-diabetic properties that protect against diabetic complications, retarding diabetes related organ degeneration and effective to hinder or prevent ailments or conditions resulting from, or exacerbated by, a chronic increase in blood sugar including: tissue degeneration, cardiovascular disease, kidney degeneration, loss of cognitive function, weight loss, visual impairment, and vasomotor symptoms which contains extract from palm leaf.
Claims
exact text as granted — not AI-modified1 . A composition with anti-diabetic property for diabetic management and prevention against oxidative stress, retarding diabetes related complications, retarding diabetes related organ degeneration and effective to hinder or prevent ailments or conditions resulting from, or exacerbated by, a chronic increase in blood sugar including: tissue degeneration, cardiovascular disease, kidney disfunction, loss of cognitive function, weight loss, visual impairment, and vasomotor symptoms, comprising an extract from leaves of Palmae family.
2 . The composition according to claim 1 , wherein the extract is prepared in a concentrated form, preferably paste or powdery form.
3 . The composition according to claim 2 , wherein the extract is a plant metabolite which is susceptible to an extraction solvent.
4 . The composition according to claim 1 , wherein the Palmae family is preferably derived from any one or combination of the species, Elaeis guineensis, Elaeis oleifera, Phoenix dactylifera and Cocos nucifera.
5 . The composition according to claim 1 , wherein compounds to be extracted from the alcohol/aqueous extracts of are to biophenols, proteins, lipids, saccharides, minerals and small peptides.
6 . The composition according to claim 5 , wherein polar solvents such as water, alcohol or acetone are used to extract the compounds.Join the waitlist — get patent alerts
Track US2012058207A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.